These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29020490)

  • 1. Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane.
    Rabani V; Montange D; Meneveau N; Davani S
    Platelets; 2018 Nov; 29(7):709-715. PubMed ID: 29020490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.
    Quinton TM; Kim S; Jin J; Kunapuli SP
    J Thromb Haemost; 2005 May; 3(5):1036-41. PubMed ID: 15869601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y
    Brambilla M; Becchetti A; Rovati GE; Cosentino N; Conti M; Canzano P; Giesen PLA; Loffreda A; Bonomi A; Cattaneo M; De Candia E; Podda GM; Trabattoni D; Werba PJ; Campodonico J; Pinna C; Marenzi G; Tremoli E; Camera M
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2042-2057. PubMed ID: 37589138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of P2Y12 polymorphisms on platelet activity but not ex-vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects.
    Li MP; Tang J; Wen ZP; Zhang YJ; Zhang W; Zhou HH; Zhang ZL; Chen XP
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):874-81. PubMed ID: 26083990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.
    Hoffmann K; Lutz DA; Straßburger J; Baqi Y; Müller CE; von Kügelgen I
    J Thromb Haemost; 2014 Nov; 12(11):1898-905. PubMed ID: 25186974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reorganization of platelet membrane sphingomyelins by adenosine diphosphate and ticagrelor.
    Haghighi F; Rabani V; Pais-De-Barros JP; Davani S
    Chem Phys Lipids; 2018 Nov; 216():25-29. PubMed ID: 30222974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist.
    Ahn YH; Lee JY; Park HD; Kim TH; Park MC; Choi G; Kim S
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27563870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
    Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
    Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
    Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ADP receptors on platelets in the growth of ovarian cancer.
    Cho MS; Noh K; Haemmerle M; Li D; Park H; Hu Q; Hisamatsu T; Mitamura T; Mak SLC; Kunapuli S; Ma Q; Sood AK; Afshar-Kharghan V
    Blood; 2017 Sep; 130(10):1235-1242. PubMed ID: 28679740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
    Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
    Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling via P2Y12 may be critical for early stabilization of platelet aggregates.
    Speich HE; Bhal V; Houser KH; Caughran AT; Lands LT; Houng AK; Bäckstrom J; Enerbäck M; Reed GL; Jennings LK
    J Cardiovasc Pharmacol; 2014 Jun; 63(6):520-7. PubMed ID: 24477045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents.
    Zhang H; Liu J; Zhang L; Kong L; Yao H; Sun H
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3598-602. PubMed ID: 22546677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
    Lei Y; Zhang B; Liu D; Zhao J; Dai X; Gao J; Mao Q; Feng Y; Zhao J; Lin F; Duan Y; Zhang Y; Bao Z; Yang Y; Mou Y; Wang S
    J Med Chem; 2020 Dec; 63(24):15752-15772. PubMed ID: 33307675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.
    Aungraheeta R; Conibear A; Butler M; Kelly E; Nylander S; Mumford A; Mundell SJ
    Blood; 2016 Dec; 128(23):2717-2728. PubMed ID: 27694321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor inverse agonist activity at the P2Y
    Khalil J; Dimofte T; Roberts T; Keith M; Amaradasa K; Hindle MS; Bancroft S; Hutchinson JL; Naseem K; Johnson T; Mundell SJ
    Br J Pharmacol; 2024 Jan; 181(1):21-35. PubMed ID: 37530222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.
    Nylander S; Schulz R
    Br J Pharmacol; 2016 Apr; 173(7):1163-78. PubMed ID: 26758983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.